Authors
Holly E. L. Evans
Daniel A. Galvão, Edith Cowan UniversityFollow
Cynthia C. Forbes
Danielle Girard
Corneel Vandelanotte
Robert U. Newton, Edith Cowan UniversityFollow
Andrew D. Vincent
Gary Wittert
Ganessan Kichenadasse
Suzanne Chambers, Edith Cowan UniversityFollow
Nicholas Brook
Camille E. Short
Document Type
Journal Article
Publication Title
Cancers
Volume
13
Issue
23
Publisher
MDPI
School
School of Medical and Health Sciences / Exercise Medicine Research Institute / Centre for Exercise and Sports Science Research
RAS ID
40502
Funders
Australian New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through a Below the Belt research grant (Short 2017)
Commonwealth Research Training Program scholarship
Freemasons Centre for Men's Health
National Health and Medical Research Council
Victorian Cancer Agency
Grant Number
NHMRC Number : 1090517
Abstract
Preliminary research has shown the effectiveness of supervised exercise-based interventions in alleviating sequela resulting from metastatic prostate cancer. However, many individuals encounter barriers that limit the uptake of face-to-face exercise. Technology-enabled interventions offer a distance-based alternative. This pilot study aimed to explore the acceptability, safety and preliminary efficacy of a web-based exercise intervention (ExerciseGuide) in individuals with metastatic prostate cancer. Forty participants (70.2 ± 8.5 years) with metastatic prostate cancer were randomised into the 8-week intervention (N = 20) or a wait-list control (N = 20). The intervention arm had access to a computer-tailored website, personalised exercise prescription and remote supervision. ExerciseGuide was deemed acceptable with a score ≥ 20 on the client satisfaction questionnaire; however, the usability score was just below the pre-specified score of ≥ 68 on the software usability scale. There were no serious adverse events reported. Moderate-to-vigorous physical activity levels between baseline and follow-ups were significantly higher (10.0 min per day; 95% CI = (1.3–18.6); p = 0.01) in the intervention group compared to wait-list control. There were also greater improvements in step count (1332; 95% CI = (159–2505); p = 0.02) and identified motivation (0.4, 95% CI = (0.0, 0.7); p = 0.04). Our findings provide preliminary evidence that ExerciseGuide is acceptable, safe and efficacious among individuals with metastatic prostate cancer.
DOI
10.3390/cancers13235925
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Comments
Evans, H. E. L., Galvão, D. A., Forbes, C. C., Girard, D., Vandelanotte, C., Newton, R. U., . . . Short, C. E. (2021). Acceptability and preliminary efficacy of a web-and telephone-based personalised exercise intervention for individuals with metastatic prostate cancer: The exerciseguide pilot randomised controlled trial. Cancers, 13(23), Article 5925.
https://doi.org/10.3390/cancers13235925